In vivo interactions between ionizing radiation, inflammation and chemical carcinogens identified by increased DNA damage responses

Radiation Research

Volumn 177, Issue 5, 2012, Pages 584-593

  McAllister, K A ^a,b   Lorimore, S A ^a   Wright, E G ^a   Coates, P J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; LIPOPOLYSACCHARIDE; METHYLNITROSOUREA; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA CONTENT; DNA DAMAGE; ENZYME INDUCTION; FEMALE; IN VIVO STUDY; INFLAMMATION; IONIZING RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; RADIATION EXPOSURE;

AGE FACTORS; ANIMALS; BONE MARROW CELLS; BYSTANDER EFFECT; CARCINOGENS; COCARCINOGENESIS; DNA; DNA DAMAGE; DRUG INTERACTIONS; FEMALE; GAMMA RAYS; HEMATOPOIETIC STEM CELLS; INFLAMMATION; LIPOPOLYSACCHARIDES; METHYLNITROSOUREA; MICE; MICE, INBRED CBA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TIME FACTORS; WHOLE-BODY IRRADIATION;

MUS;

EID: 84861399185     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2690.1     Document Type: Article

References (46)

1. Gilbert ES. Ionising radiation and cancer risks: what have we learned from epidemiology? Int J Radiat Biol. 2009; 85:467-82.
2. Mullenders L, Atkinson M, Paretzke H, Sabatier L, Bouffler S. Assessing cancer risks of low-dose radiation. Nat Rev Cancer. 2009; 9:596-604.
3. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, et al. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res. 2007; 167:396-416. (Pubitemid 351292972)
4. Boedeker W, Backhaus T. The scientific assessment of combined effects of risk factors: different approaches in experimental biosciences and epidemiology. Eur J Epidemiol. 2010; 25:539-46.
5. Anderson LM. Environmental genotoxicants/carcinogens and childhood cancer: bridgeable gaps in scientific knowledge. Mutat Res. 2006; 608:136-56. (Pubitemid 44322063)
6. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007; 121:2373-80. (Pubitemid 350022405)
7. Eden T. Aetiology of childhood leukaemia. Cancer Treat Rev. 2010; 36:286-97.
8. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res. 2008; 659:15-30.
9. Porta C, Riboldi E, Sica A. Mechanisms linking pathogens-associated inflammation and cancer. Cancer Lett. Epub 2010.
10. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009; 30:1073-81.
11. Ohshima H, Tazawa H, Sylla BS, Sawa T. Prevention of human cancer by modulation of chronic inflammatory processes. Mutat Res. 2005; 591:110-22. (Pubitemid 41654843)
12. Ng AK, Kenney LB, Gilbert ES, Travis LB. Secondary malignancies across the age spectrum. Semin Radiat Oncol. 2010; 20:67-78.
13. Stjernfeldt M, Berglund K, Lindsten J, Ludvigsson J. Maternal smoking and irradiation during pregnancy as risk factors for child leukemia. Cancer Detect Prev. 1992; 16:129-35.
14. Zahm SH, Devesa SS. Childhood cancer-Overview of incidence trends and environmental carcinogens. Environ Health Perspect. 1995; 103:177-84.
15. Cory-Slechta DA. Studying toxicants as single chemicals: Does this strategy adequately identify neurotoxic risk? Neurotoxicology. 2005; 26:491-510. (Pubitemid 41178971)
16. Manti L, D'Arco A. Cooperative biological effects between ionizing radiation and other physical and chemical agents. Mutat Res. 2010; 704:115-22.
17. Mothersill C, Seymour C. Implications for environmental health of multiple stressors. J Radiol Protect. 2009; 29:A21-A8.
18. Sexton K, Hattis D. Assessing cumulative health risks from exposure to environmental mixtures-Three fundamental questions. Environment Health Perspect. 2007; 115:825-32. (Pubitemid 46785055)
19. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003; 290:465-75. (Pubitemid 37430500)
20. Lorigan P, Radford J, Howell A, Thatcher N. Lung cancer after treatment for Hodgkin's lymphoma: a systematic review. Lancet Oncol. 2005; 6:773-9. (Pubitemid 41430718)
21. Lord BI, Woolford LB. Induction of stem cell cycling in mice increases their sensitivity to a chemical leukaemogen: implications for inherited genomic instability and the bystander effect. Mutat Res. 2002; 501:13-7. (Pubitemid 34270646)
22. Imaoka T, Nishimura M, Teramoto A, Nishimura Y, Ootawara M, Osada H, et al. Cooperative induction of rat mammary cancer by radiation and 1-methyl-1-nitrosourea via the oncogenic pathways involving c-Myc activation and H-ras mutation. Int J Cancer. 2005; 115:187-93. (Pubitemid 40586726)
23. Kantorowitz DA, Thompson HJ, Furmanski P. Effect of high-dose, fractionated local irradiation on MNU-induced carcinogenesis in the rat mammary gland. Carcinogenesis. 1995; 16:649-53.
24. Yamauchi K, Kakinuma S, Sudo S, Kito S, Ohta Y, Nohmi T, et al. Differential effects of low-and high-dose X-rays on N-ethyl-N-nitrosourea- induced mutagenesis in thymocytes of B6C3F1 gpt-delta mice. Mutat Res. 2008; 640:27-37.
25. Kakinuma S, Yamauchi K, Amasaki Y, Nishimura M, Shimada Y. Low-dose radiation attenuates chemical mutagenesis in vivo. J Radiat Res (Tokyo). 2009; 50:401-5.
26. Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment-tumorigenesis and therapy. Nat Rev Cancer. 2005; 5:867-75.
27. Wright EG. Manifestations and mechanisms of non-targeted effects of ionizing radiation. Mutat Res. 2010; 687:28-33.
28. Coates PJ, Lorimore SA, Wright EG. Cell and tissue responses to genotoxic stress. J Pathol. 2005; 205:221-35. (Pubitemid 40227993)
29. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res. 2003; 159:581-96. (Pubitemid 36539237)
30. Asur RS, Thomas RA, Tucker JD. Chemical induction of the bystander effect in normal human lymphoblastoid cells. Mutat Res. 2009; 676:11-6.
31. Coates PJ, Lorimore SA, Wright EG. Damaging and protective cell signalling in the untargeted effects of ionizing radiation. Mutat Res. 2004; 568:5-20. (Pubitemid 39458292)
32. Lorimore SA, Coates PJ, Wright EG. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene. 2003; 22:7058-69. (Pubitemid 37386675)
33. Burr KL, Robinson JI, Rastogi S, Boylan MT, Coates PJ, Lorimore SA, et al. Radiation-induced delayed bystander-type effects mediated by hemopoietic cells. Radiat Res. 2010; 173:760-8.
34. Gowans ID, Lorimore SA, McIlrath JM, Wright EG. Genotype-dependent induction of transmissible chromosomal instability by gamma-radiation and the benzene metabolite hydroquinone. Cancer Res. 2005; 65:3527-30. (Pubitemid 40616324)
35. Lorimore SA, McIlrath JM, Coates PJ, Wright EG. Chromosomal instability in unirradiated hemopoietic cells resulting from a delayed in vivo bystander effect of gamma radiation. Cancer Res. 2005; 65:5668-73. (Pubitemid 40911168)
36. Watson GE, Lorimore SA, Macdonald DA, Wright EG. Chromosomal instability in unirradiated cells induced in vivo by a bystander effect of ionizing radiation. Cancer Res. 2000; 60:5608-11.
37. Watson GE, Pocock DA, Papworth D, Lorimore SA, Wright EG. In vivo chromosomal instability and transmissible aberrations in the progeny of haemopoietic stem cells induced by high-and low-LET radiations. Int J Radiat Biol. 2001; 77:409-17. (Pubitemid 32281124)
38. Coates PJ, Lorimore SA, Lindsay KJ, Wright EG. Tissue-specific p53 responses to ionizing radiation and their genetic modification: the key to tissue-specific tumour susceptibility? J Pathol. 2003; 201:377-88. (Pubitemid 37408258)
39. Valenzuela MT, Guerrero R, Nunez MI, Ruiz De Almodovar JM, Sarker M, de Murcia G, et al. PARP-1 modifies the effectiveness of p53-mediated DNA damage response. Oncogene. 2002; 21:1108-16. (Pubitemid 34174523)
40. Coates PJ, Robinson JI, Lorimore SA, Wright EG. Ongoing activation of p53 pathway responses is a long-term consequence of radiation exposure in vivo and associates with altered macrophage activities. J Pathol. 2008; 214:610-6. (Pubitemid 351482276)
41. Coates PJ, Rundle JK, Lorimore SA, Wright EG. Indirect macrophage responses to ionizing radiation: implications for genotype-dependent bystander signaling. Cancer Res. 2008; 68:450-6. (Pubitemid 351380071)
42. Lorimore SA, Chrystal JA, Robinson JI, Coates PJ, Wright EG. Chromosomal instability in unirradiated hemaopoietic cells induced by macrophages exposed in vivo to ionizing radiation. Cancer Res. 2008; 68:8122-6.
43. Lorimore SA, Mukherjee D, Robinson JI, Chrystal JA, Wright EG. Long-lived inflammatory signaling in irradiated bone marrow is genome dependent. Cancer Res. 2011; 71:6485-91.
44. Mukherjee D, Coates PJ, Lorimore SA, Wright EG. The in vivo expression of radiation-induced chromosomal instability has an inflammatory mechanism. Radiat Res. 2012; 177:18-24.
45. Walburg HE, Cosgrove GE, Upton AC. Influence of microbial environment on development of myeloid leukemia in x-irradiated RFM mice. Int J Cancer. 1968; 3:150-4.
46. Lorimore SA, Coates PJ, Scobie GE, Milne G, Wright EG. Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? Oncogene. 2001; 20:7085-95. (Pubitemid 33052200)